Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
*Architects: Biotechnology_Personalized, Precision, Preemptive Medicines

Cleave Biosciences

Attachments

By matching its targeted drugs to subsets of patients whose tumors are regulated by the same pathways, the company will identify the patients most likely to benefit and increase the probability of success in the clinic.
Cleave Biosciences Nabs $42M, Veteran Execs, to Chase Personalized Cancer Therapies (2011)
Cleave Biosciences Raises 42 Million in Series A Financing for Novel Cancer Therapies (2011)
Founded 2010
Protein homeostasis remains one of the last underexplored territories for harvesting new drugs to treat cancer
San Francisco, California
Series A investors include U.S. Venture Partners, 5AM Ventures, Clarus Ventures, OrbiMed Advisors and Astellas Venture Management.
The financing will support multiple small molecule discovery and development programs in the area of protein homeostasis, which are currently undergoing lead identification and optimization.